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Abstract
Mycobacterium tuberculosis is the etiological agent of tuberculosis. It is a pathogen that continues to draw international concerns particularly due to the emergence of
multi-drug resistance and to the difficulties associated with the diagnosis and treatment of latent tuberculosis. A key process in the pathogenesis of this disease is the
interaction between this pathogen and host macrophages. Invasion of the macrophages protects the pathogen from attack by the immune system, allows it to multiply
while protected within the macrophages, and alters the immune response as it influences the profiles of the cytokine and chemokine responses. Key to the intracellular
survival of the pathogen within the macrophages is the specific interaction between the pathogen and its virulence factors with the host. This review provides an a
summary of pertinent literature on the topic of macrophage receptors utilized by the pathogen, its survival strategies within the macrophage, and the general profile of
immune signalling upon exposure to the pathogen. The importance of specific macrophage receptors and certain components of the pathogen to the direction of the
immune response are also discussed.
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Introduction
Certain members of the Mycobacteria, particularly the slow
growers, are facultative intracellular aerobic pathogens.
Phylogenetically members of this family are classified as Gram-positive
bacteria. Members of the Mycobacteria share a characteristic cell wall
that is hydrophobic, waxy and rich in mycolic acid. The cell wall
consists of the hydrophobic mycolate layer and a peptidoglycan layer
held together by arabinogalactan (AG), a biopolymer consisting of
galactose and arabinose [1-3]. Other molecules and biopolymers found
within the cell envelop includes lipomannans (LM),
lipoarabinomannans (LAM), glycolipids, glycoproteins [1-3].
Pathogenic mycobacteria uses these surface-exposed molecules
attach, enter, and infect host cells. These surface molecules specifically
bind certain surface receptors on the host cell; most relevant in the
study of pathogenesis of tuberculosis (TB) are the alveolar
macrophages [4]. The process of phagocytosis is the first critical step
for the infection of macrophages by mycobacteria and it involves
microbial ligands and macrophage surface receptors that are now well
characterized. Following phagocytosis a complex network of
intracellular signaling changes take place and result in the survival of
the internalized pathogen and causes attenuation in the secretion of
and response to cytokines by the macrophage; events that eventually
dictate the outcome of the disease.
Mycobacterium tuberculosis is the etiological agent of TB and it is
endowed with many virulence factors that confer resistance to survive
and multiply within the host. This pathogen infects large numbers of
people every year around the globe and, as the World Health
Organization reports [5], this disease remains to be one of the main
causes of death. The initial infection can be active or latent, where the
symptoms of the disease may be absent for years or decades. The latent
form of the disease may at any time become active; a case referred to as
reactivation TB. It is possible that about one third of the human
population is latently infected with M. tuberculosis [5]. Although the
initial and primary target of the pathogen is the human alveolar
macrophage the infection can spread over to other organs from the
lungs. The outcome of the infection depends on the first interactions
between Mycobacterium tuberculosis and human cells and on the
surface features of each and the virulence factors that the pathogen
elaborates during the infection. The intracellular fate of this pathogen
in the host depends on which receptor is involved and the interaction
with phagosomal membrane. At the cellular level, the response of the
host macrophage is regulated by intracellular signalling networks
activated by the interaction with the pathogen and its virulence factors.
Macrophages are important cells of the innate immune response and
have a key role in inactivating pathogens and stimulating the first steps
of immune responses. After its phagocytosis within the macrophages,
Mycobacterium tuberculosis uses certain mechanisms to survive
within the host and highly interfere with the signalling pathways of the
cells; thus modulating the host immune response. This interference
occurs at many levels: inhibition of phagosome maturation, down
regulation of signalling pathways that lead to activation of the
macrophage and to the immune response, inhibition of antigen
presentation and inhibition of reactive oxygen/nitrogen intermediates.
Importance of cellular immunity in tuberculosis
The type of cells first recruited to the site of the infection is typically
the neutrophils. They are attracted to the site of the infection by the
interleukins secreted by infected alveolar macrophages and, once
arrived in the lungs, they differentiate to form other mature
macrophages [6]. These cells are very important in phagocytosis and
intracellular killing action of bacteria and they can also help induce the
adaptive immune response through cytokines signalling. In most of the
cases, innate immune system is not effective to destroy completely the
pathogens so the adaptive immunity is activated. The adaptive immune
cells have a central role in response against tuberculosis. Among all
these cells, CD4 and CD8 T cells are important in producing INF-γ,
one of the main cytokines involved in the immune response. Its
importance has been shown in some studies [7-10] where INF-γ gene
knockout or the lack of its receptor led to higher susceptibility to
Mycobacterium tuberculosis.
CD4 T cells have a central role in the protective response and also in
the latent disease. Some experiments [11] have demonstrated CD4 T
cells role and functions. In a model of latent tuberculosis, the infection
was reactivated after the depletion of this kind of cells and the amount
of CD8 T cells and INF-γ production by them was increased to
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compensate the lack of CD4 T cells. However, this stronger response by
CD8 T cells was not enough to fight the infection, suggesting the
importance of CD4 T cells. Other functions of these immune cells have
been found: they can induce the apoptosis of infected macrophages
[12], they produce a wide number of cytokines such as IL-2 and TNF-α
[13], they stimulate the activation of macrophages through direct
contact and their production of relevant cytokines as IL-15, IL-10 and
IL-10 [14,15]. NK and CD8 T cells contribute as well. CD8 T cells help
by producing cytokines and lysing the infected cells [16,17]; NK cells
recognize and destroy infected host cells, produce INF-γ to enhance
the immune response and induce the expansion of T cells by
stimulating macrophages to produce cytokines such as IL-12, IL-15
and IL-18 [18,19].
Autophagy
Autophagy is one of the main innate immune defense mechanisms
used by infected macrophages to destroy Mycobacterium tuberculosis.
With autophagy, the cells can degrade their own intracellular
environment to control the infection [20]. When the macrophages are
stimulated and the pathogens are engulfed, their activation leads to the
production of IRGM1, a GTPase involved in stimulation of INF-γ that
is the key cytokine in inducing autophagy [21]. Singh and co-workers
[22] have shown in their work that IRGM1 probably translocate in the
mitochondrial to regulate the autophagy in association with
mitochondrial fission. Mycobacteria have evolved a strategy to survive
also to autophagy. It has been found by Shin and colleagues a gene
called eis (“enhances intracellular bacterial survival”) that is present in
Mycobacterium tuberculosis genome and can inhibit autophagy
increasing the probabilities of mycobacterial survival.
Pathogenesis of tuberculosis
Lurie [23] has found that the pulmonary tuberculosis can be divided
into four main stages. First, the bacilli have to be inhaled and,
consequently, engulfed by the alveolar macrophages; during this stage,
most bacteria are destroyed by microbicidal skills of the host cells.
Mycobacteria that survive to this first intracellular destruction can
start multiplying and, thereby, cause the macrophages disruption
leading, in most of the cases, to an active disease. Because of that and
because of the pro-inflammatory chemokines and cytokines released
by the macrophages, other macrophages and monocyte-derived
dendritic cells are attracted to the lungs to limit the infection. These
immune cells can ingest the bacteria but not neutralize them; for this
reason, at this second stage, mycobacterial grown and multiplication
can be evident in the patient with little tissue damage being produced.
Two or three weeks after the infection, T cells-mediated immunity
develops with antigen-specific T lymphocytes and starts activating
macrophages to kill the intracellular pathogens. At this stage, the
bacilli growth stops and the disease can become stationary. The
outcome of the infection depends on the successful interaction
between T cells and infected macrophages and on the action of many
factors such as INF-γ and TNF-α that can regulate mycobacterial
growth, granuloma formation and initiation of adaptive immune
response. The innate and adaptive immune systems are very important
to determinate the outcome of the exposure to mycobacteria. A small
percentage of individuals can remain uninfected because of a very
effective immune system; however, in the majority of them, the innate
immunity cannot protect them from the infection and the adaptive
immunity is activated. The bacteria have evolved the skill to live in
balance with human adaptive immune system cells: in this case, the
result of infection is a latent disease and it can be maintained for the
lifetime of the patient. If the balance is perturbed, the bacteria start
reactivating and replicating and a reactivation of the disease occurs,
leading to active and contagious tuberculosis. The reactivation of latent
disease can depend on many factors like features of the pathogens and
the host, but it always occurs if the immunity is suppressed or
compromised.
Granuloma
After the initial infection of macrophages, the immune response is
activated: the macrophages begin to produce inflammatory cytokines
and chemokines that induce the immunity cells migration to the site of
infection. Once macrophages and dendritic cells engulfed the bacteria,
they migrate to the lymph nodes to present the mycobacterial antigen
to CD4 and CD8 T cells and activate them.
These lymphocytes migrate back to the lungs following the
chemokines as signal [24-26]. If the innate and adaptive immunity are
not able to rapidly kill the pathogens, their migration to the site of
infection can lead to the formation of granuloma. Granuloma is the
characteristic histopathological feature of human pulmonary
tuberculosis in which the bacteria can persist for many years.
Granulomas are mainly composed of macrophages, neutrophils,
dendritic cells and lymphocytes that are located around the bacteria to
limit the spread of infection. When the granuloma is mature,
fibroblasts are also present to surround the whole structure [27]. In the
middle of granuloma, there are mature mycobacteria that develop a
necrotic and caseous center, probably formed by the lipids released by
the macrophages that, within the granulomas, are lipid-rich cells [27].
Besides limiting the spread of infection, this structure physically
contains the bacteria and hinders their growth by stressing them with
starvation, exposition to reactive oxygen and nitrogen intermediates
and hypoxia. From some recent studies [27,28], it has been shown that
mycobacteria can survive to those stresses by using host cholesterol as
nutrition and using their proteasomes to fight oxidative stress (Figure
1). In most of the cases, granuloma is able to contain the infection but
if some bacteria survive, it leads to a latent disease.
Figure 1: A schematic section through a granuloma highlighting the
arrangement of different host cell types. The interior becomes
liquefied mostly over time but live bacilli persist within.
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Mechanisms used by mycobacteria to evade immune system
and survive in the host cells
Phagosome maturation: The formation of a new phagosome is the
result of the uptake of mycobacteria by phagocytes, a process that is
meant to neutralize the pathogen; this vesicle is then manipulated by
the pathogen to ensure its intracellular survival. During the normal
process, the nascent phagosome follows a progressive maturation
process through a sequential fusion with early endosomes, late
endosomes and then lysosomes. Mycobacteria-containing phagosomes
are not secluded from the whole cell vesicular network as it fuses with
early endosomes and thus allow the pathogen to access nutrients.
Beyond this step the phagosome maturation process is blocked. The
molecular bases of this blockage have been somewhat characterized.
Manipulation of intraphagosomal pH: Mycobacteria can modulate
and inhibit the acidification of the phagosomal vesicle by expressing a
urease and a glutamine synthetase that increase the intraphagosomal
pH producing ammonia. This alkaline pH hinders the transport of
material from early endosomes to late endosomes arresting the
phagosome maturation [29]. In human macrophages Jung and
Robinson [30] have shown that infected macrophages express the P28
and the Epstein-Barr virus induced gene s (EBI3) proteins and the cell
secretes the active IL-27. The IL-27 then engages its receptor on the
same cell and down regulates the expression of the v-ATPase. This also
contributes to reduced acidification of the phagosome. IL-27 signalling
also negatively regulates Cathepsin D and CD63 (lysosomal integral
membrane protein-1; LIMP-1). Both of the latter events are important
for the maturation of the phagosome as well.
Manipulation of phagosomal membrane: For its maturation, the
phagosome needs the assembly of appropriate fusion machinery on the
phagosomal membrane for the interaction with early and late
endosomes and then with the lysosomes. The vesicle fusion is, in part,
regulated by Rab proteins which belong to the GTPase family. In
particular, mycobacteria-containing phagosomes block the step where
Rab7 is involved. Rab7 is a small GTPase that is involved in the late
endocytic compartments and it controls the maturation of early
endosomes to late endosomes. Mycobacteria blocks the Rab7
acquisition or interfere with the factors involved in its recruitment to
the phagosomal membrane; thereby preventing phagosome maturation
[31,32].
Another Rab protein important for the maturation process is Rab14
(Figure 2). This protein transiently associates with the phagosomal
membrane and is normally absent in the late stages of the process. It
has been shown that mycobacteria-containing phagosomes block the
release of Rab14 from the phagosomal membrane [33]. Using
overexpression of dominant-negative mutants and knockdown of
endogenous Rab14 using si-RNA for Rab14 reverses the maturation
block [33]. Phosphatidylinsoitol-3-phosphate (PIP3) is another
phagosomal membrane marker important for the phagosomal
maturation process (Figure 2).
Phagosomes undergoing normal maturation have PIP3 in the
phagosomal membrane. Phagosomes containing M. tuberculosis have
been shown to release PIP3 [34]. This pathogen secretes an acid
phosphatase called SapM [35]. This enzyme has been shown to
hydrolyse PIP3 during infection of macrophages with M. tuberculosis
[34]. This activity results in the exclusion of PIP3 from the phagosomal
membrane and further contributes to blocking the maturation process.
A glycolipid of M. tuberculosis known as ManLAM (mannose-capped
Lipoarabinomannan) is another surface component that is involved in
blocking phagosome maturation. This glycolipid is essentially a
glycosylated phosphatidylinositol and has been shown to interfere with
the phagosomal acquisition of lysosomal content and syntaxin 6.
Syntaxin 6 is required to recruit the early endosome auto antigen 1
(EEA1) [36], events dependent on the activity of the
phosphatidylinositol 3-kinase and is required for proper maturation of
the phagosome [37].
Figure 2: Proposed role of the various virulence factors of
Mycobacterium tuberculosis in blocking the maturation of the
pathogen-containing phagosome. PIP3 levels are affected by the
phosphatase activity of SapM. PIP3 and Ca2+ levels are affected by
ManLAM. These effects have consequences on recruitment of
vesicle fusion effectors such as Rab 7, Syntaxin 6, and EEA1. The
mPTPB has a role in down regulating ERK 1/2 signalling and up
regulating STAT 3 signalling; effectively contributing to the
maturation block.
Manipulation of host cytoskeletal system: Mycobacteria can also
affect the interaction of the phagosome with the host cell actin
cytoskeleton. When the pathogen is engulfed by the macrophage, the
coronin1 accumulates around the bacteria-containing phagosome.
Coronin1 is a cell cortex protein with tryptophan and aspartate
residues and with actin binding sites important to promote the
interaction between the phagosome and the cell cortical actin network.
Some studies [38-40] have shown that the accumulation of this coat
protein could be critical to prevent the function of the factors that
promote the phagosome maturation.
Modulation of antigen presentation
After the infection, the pathogens move from the lungs to the lymph
nodes within the dendritic cells that are the antigen-presenting cells
that can present the antigen to T cells and activate the adaptive
immune response. The pathway for processing and presentation of the
antigens is a key process for the activation and the function of immune
system. There are three different pathway of antigen presentation:
1) Mycobacterial peptide antigens can be processed and presented
on MHC class II molecules by antigen-presenting cells (APCs) to CD4
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T cells. Once these lymphocytes are activated, they can start killing the
intracellular bacteria and the infected host cells by producing INF-γ
and TNF-α.
2) Mycobacterial peptide antigens can be processed and presented
on MHC class I molecules by APCs to CD8 T cells that can kill
intracellular bacteria and infected cells by producing toxic granules.
3) Mycobacterial lipid or glycolipid antigens such as ManLAM and
mycolic acids can be recognized and neutralized by natural killer cells
(NK) or CD8 T cells. Mycobacteria have evolved some strategies to
modulate and interfere with antigen presentation. While the
processing of MHC class I molecules does not appear to be affected,
mycobacterial surface ManLAM can attenuate the expression of MHC
class II molecules induced by INF-γ on the APCs. This mechanism is
not clearly understood yet, but it could involve an intracellular
sequestration of non-mature MHC class II heterodimers, an inhibition
of INF-γ gene expression, and/or a down regulation of class II
molecules trans activator expression [41,42]. The MHC class II main
trans activator is CIITA. In the normal pathway, MHC class II
expression is induced by INF-γ that is produced after infection. INF-γ
binding to its receptor leads to Janus kinase-signal transducer and
activator of transcription (JAK-STAT) activation, resulting in STAT1α
phosphorylation and dimerization. In this way, STAT1α can
translocate into the nucleus and bind to the promoter GAS leading to
the induction of CIITA that can activate MHC class II genes expression
(Figure 3). Mycobacteria can interfere with this pathway through Toll-
like receptors (TLR), leading to decreased expression of MHC class II
molecules. TLR signalling occurs through MYD88 and downstream
activation of nuclear factor kB (NF-kB) and mitogen-activated protein
kinase (MAPK). In the nucleus, this pathway can induce the
expression of many genes such as C/EBP that, by binding to CIITA
promoter, can inhibit its expression and, thereby, MHC class II
molecules expression and antigen presentation.
Figure 3: Major intracellular signalling pathways activated by
pathogenic mycobacteria or their components.
Another mycobacterial molecule can further down regulate the
production of MHC class II molecules: the 19-kDa lipoprotein. From
some studies [43], it has been found that this component can hinder
the antigen processing and presentation and its inhibitory effect
depends on Toll-like receptor 2 (TLR2) that is very important in
initiating the immune response after mycobacteria infection. The
TLR2-dependent interference with the antigen presentation occurs
only after the treatment with the 19-kDa lipoprotein and it is a strategy
for the bacteria to evade the immune response. Ramachandra and
colleagues [44] have showed evidence that mycobacteria can inhibit
the antigen processing and presentation. Phagosomes containing M.
tuberculosis are competent antigen-presenting organelles in which the
MHC class II antigens are processed with mycobacterial antigen. The
phagosomes with live pathogens show a smaller amount of this
complex, compared to the phagosomes with dead bacilli. This suggests
that live mycobacteria can attenuate antigen processing and
presentation, besides phagosome maturation.
Reactive nitrogen intermediates and nitric oxides
After the infection with mycobacteria and the early activation of
innate immunity, T cells are stimulated to produce INF-γ. This
molecule can further stimulate the macrophage and up regulate the
activity of nitric oxide synthase 2 (NOS2) and, thereby, the production
of reactive nitrogen intermediates (RNIs) by macrophage. NOS2
catalyses the nitric oxide production (NO) from arginine; NO can
react with some molecules to form other RNIs that can damage
bacterial DNA, proteins and lipids [18,45]. RNIs are essential for the
containment of the infection and for killing mycobacteria because
these molecules are toxic for this kind of pathogen [18,46]. Moreover,
nitric oxide also reacts with glutathione to form another molecule that
is toxic for the bacteria: S-nitro glutathione [47]. These strategies that
occur into the macrophages have been demonstrated in some studies:
Rosen Zweig et al [48] have found that mutation of INF-γ receptor
leads the individuals to have a strong susceptibility to mycobacteria
infection; their experiment suggests that INF-γ and its pathway in the
macrophage is very important to mediate the anti-mycobacterial
action.
From other studies [49], we know that in the infected alveolar
macrophages a high level of NOS2 is expressed and an inhibition of
this enzyme can lead to have an increase of pathogens growth and
repression of NOS2 anti-mycobacterial activity. Moreover, it has been
shown, from other experiments [50-53], that if we inhibit NOS2
pathway and RNIs production, the susceptibility to M. tuberculosis is
strongly enhanced and the persistent infection can be reactivated. Like
for the other mechanisms of defense that occur in the host cells, M.
tuberculosis has evolved some strategies to survive even in presence of
RNIs. By screening a DNA library derived from a kind of M.
tuberculosis highly resistant to RNIs, Ehrt and colleagues [54] have
discovered noxR1 as a gene that confers resistance to reactive oxygen
intermediates (ROI) and to RNIs in E. coli and M. smegmatis, and
noxR3 in Salmonella typhimurium [54,55].
Macrophage receptors and signalling pathways involved in
infection by mycobacteria
Signalling in the macrophage is at the cell surface by the interaction
between its receptors and pathogen. Once phagocytized, it continues to
create new surface and secreted molecules within the host cell to
interact with the macrophage-signalling pathway. M. tuberculosis
interacts with many cellular receptors including the complement
receptor types 1, 3 and 4 (CR1, CR3 and CR4) [56], the mannose
receptor [57,58], the surfactant protein A receptor (SPA-R) [58,59],
Toll-like receptor (TLR) [60], scavenger receptor [61], CD14 [62] and
dendritic cell-specific intercellular adhesion molecule-3- grabbing non
integrin (DC-SIGN) [63,64]. The interaction of bacteria with
macrophages can be direct or mediated by the host components. For
the direct communication, are implicated the mannose receptor or the
complement receptor type 3 and the surface polysaccharides and
glycoproteins. There is a direct interaction also between lipoproteins
and lipopolysaccharides (LPS) and the Toll-like receptor.
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The mediated interaction involves some host molecules as
antibody’s Fc receptor, surfactant protein A receptor (SPA-R),
complement receptor types 1, 3 and 4, and CD14. All these
macrophage receptors are engaged in specific signalling pathways that
lead to phagocytic uptake of the pathogen, phagosome maturation,
and/or cytokine release. The M. tuberculosis infection does not involve
only one receptor and its pathway, but multiple receptors play different
roles during the infection.
Especially, it has been shown that the binding between mannose
receptor and ManLAM can interfere, block the phagosome maturation
and mediate phagocytosis of mycobacteria. This has been
demonstrated by Kang and co-workers [65] who have found that the
phagosome-lysosome fusion, during the uptake of ManLAM
microspheres, was highly reduced in normal human macrophages but
not in the cells lacking the mannose receptors [65]. The binding of
ManLAM inhibits the increase of the cytosolic calcium level in the
macrophages and, in this way, also the interaction between calmodulin
and phosphatidylinositol 3 kinase(PI3K). Thereby, the recruitment of
Rab proteins and antigen 1 is arrested. Antigen 1 is necessary for the
delivery of lysosomal components from Golgi network to the
phagosome and for their fusion. This process of phagosome-lysosome
fusion inhibition is specific for ManLAM and mannose receptor and it
does not occur if Man LAM binds to another receptor. When
mycobacteria are internalized in the phagosomes, their surface
molecules, including lipids, are released into the endocytic network
and contribute to macrophage infection. Phagosome maturation
depends on membrane-associated proteins and on the properties of
the lipid bilayer. The mycobacterial lipids are hydrophobic molecules
that confer solubility on the biological membranes; they can intercalate
into the host cell membranes altering their physical properties and
lipid composition or interact with membrane-associated receptors if
they are lipids bearing peptides or oligosaccharides. The insertion of
mycobacterial lipids into the host cell membranes can lead to the block
of phagosome maturation through some different processes as
alteration of the lipid bilayer, formation of phospholipid domains,
constrictions of membrane movements and alteration in membrane
fluidity and permeability.
Toll-like receptors and its pathway
One of the most important key receptors in macrophages is the Toll-
like receptor (TLR). They are called pattern-recognition receptors
(PRRs) because they recognize and interact with pathogen-associated
molecular patterns (PAMPs) that are molecules associated with the
pathogens that are recognized by cells of the innate immune system
through Toll-like receptors and the other pattern recognition receptors.
TLRs are trans membrane proteins with an extracellular domain with
motifs rich in leucine to recognize microbial products. The result of
TLR activation is the production of pro-inflammatory cytokines to
have a protective response. The production of this type of cytokines by
TLR pathway is mediated by NK-Kb, while the production of the last
factors is mediated by extracellular signal-regulated kinase (ERK1/2)
and p38 through the activities of GTPase, atypical protein kinase C
(PKCζ) and phosphatidylinositol 3-kinase (PI3K) [66]. The bacteria or
their components phagocytosis by macrophages also activates
sphingosine kinase (SPK) and increases the intracellular calcium levels
leading to the activation of PKCα/β and Ca2+/calmodulin-dependent
kinase (CamK), respectively. Both phagocytosis signalling and TLR
signalling converge downstream on ERK1/2 [67]. ERK1 and ERK2
belong to the mitogen activated protein kinase (MAPK) family. Some
other MAP kinases are JNK and p38 that, with ERK1/2, are the most
important MAPK involved in mycobacteria-infected macrophages.
When the levels of ERK1/2 and the production of TNF-α increase, the
result is the activation of the macrophages. Conversely, when p38
activity is elevated, the production of mycobacterium-induced IL-10
increases. The balance between these signals is an important factor that
influences the macrophage capability to kill the pathogen. The results
of macrophage infection by non-pathogenic mycobacteria are high
levels of TNF-α and low levels of IL-10, and this leads to the activation
of the macrophage and suppression of the bacterium.
Infection of macrophages with pathogenic mycobacteria, conversely,
leads to opposite result: high levels of IL-10 and low levels of TNF-α
leading to the inhibition of macrophage activation and survival of the
pathogen.
Stat pathway
Although seven members of the STAT family have been identified
thus far in mammalian systems it appears that STAT1, STAT4, and
STAT3 are the most involved in mycobacterial infections. STAT 1 and
STAT 4 are homologous and produce similar effects upon activation;
that is pro-inflammatory and anti-proliferative effects. STAT3
activation has the opposite effects and is associated with anti-
inflammatory, anti-apoptotic, and pro-proliferative effects [68].
Activation of STAT1 and STAT4 pathways is the result of the
stimulation of macrophages by INF-γ and IL-12, respectively. INF-γ is
a cytokine produced by T cells and natural killer cells. When the
macrophages are stimulated and activated by pathogens, their gene
expression is altered and these cells produce cytokines and chemokines
that stimulate T cells and natural killer cells. In this way, INF-γ is
produced and further activates macrophages and enhances their
bactericidal activities [69]. This pathway is not responsive or
suppressed during macrophage infection with M. tuberculosis [70].
STAT3 pathway on the other hand appears to be more active or up
regulated during such infections particularly as a result of increased
secretion of IL-27 [70]. In both cases however, suppressor of cytokine
signal negative regulator-1 and -3 (SOC-1 and SOC-3) are up
regulated and the STATs pathway is down regulated as a consequence
[71]. It can therefore be concluded that the final response of the
macrophage to the infection is determined by how these two pathways
with opposing effects are balanced by the SOCs (Figure 4).
C-type lectin receptor
The C-type lectin receptors (CLRs) are calcium-dependent glycan-
binding proteins with a carbohydrate-binding C-type lectin domain
[72]; these receptors are very important in mycobacterial binding and
in inducing inflammatory responses because they detect the presence
of carbohydrate-rich surface molecules of mycobacteria. This family of
receptors includes a wide number of proteins with one or more C-type
lectin-like domains, as selectins, collectins, proteoglycans and
endocytic and phagocytic receptors like mannose receptors and
complement receptors [72].
CLRs have a cytoplasmatic domain that mediates some downstream
events as endocytosis and signal transduction, activated after its
binding to the ligand. Some of the biological mechanisms activated by
the interaction with mycobacteria are the pro-inflammatory response
and the anti-inflammatory response.
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Figure 4: Major intracellular pathways activated in macrophages
following exposure to pathogenic mycobacteria or their
components and leading to proinflammatory cytokine secretion.
Pro-inflammatory response: The recognition of mycobacterial
molecules by CLRs leads to the induction of expression of pro-
inflammatory cytokines as IL-6, IL-2 and TNF and their production by
the macrophages. These cytokines are essential for the immune
response against mycobacterial infection [73,74].
Anti-inflammatory response: The binding between CLRs and
mycobacteria also induces the production of anti-inflammatory and
immunosuppressive factors as IL-10 and TGF-β [75,76].
The respiratory system and its mucosal sites continually touch the
outer environment therefore it needs a quick and efficient immune
system. The respiratory ways are exposed not only to pathogens but
also to many foreign particles and allergens, which can cause an
unnecessary and dangerous reaction like chronic inflammation
responses and damages in local tissues. For this reason, an additional
mechanism to control and to shut down the pro-inflammatory
response is necessary. CLRs have this role and help to protect the tissue
integrity: they stimulate the production of anti-inflammatory
cytokines as IL-10 and TGF-β. Once IL-10 is produced, it activates a
signalling pathway which is involved in the control of immune system,
especially in mucosal sites where the exposure to external environment
and foreign pathogens is continuous [77-80]. If these factors are
excessively produced, the result is a change in macrophages killing
ability, a decrease of production and action of pro-inflammatory
cytokines and a prevention of immune system cells recruitment to the
site of infection. In the case of mycobacteria infection, the anti-
inflammatory factor IL-10 production can be further stimulated by the
pathogen that has evolved this mechanism to survive into the host
cells. Mycobacteria can bind to DC-SIGN to manipulate the immune
response and increase the IL-10 concentration. Interacting with DC-
SIGN, mycobacteria can induce the IL-10 production because
ManLAM is able to activate the kinase Raf1 pathway: this leads to the
transcription factor NF-kB phosphorylation and, in this manner, it can
enter the nucleus and enhance the IL-10 transcription [63,75]. In some
studies, it has been shown the inhibiting activity of mycobacteria-
induced IL-10 on the maturation of dendritic cells and on their
recruitment to the site of the infection [81]. It also hinders the activity
of CD4 and CD8 T cells by down regulating the costimulatory factors
on macrophages and inhibits the T cells proliferation [82].
Complement receptor types 1, 3, & 4
There are two distinct structural forms of the phagocyte
complement receptors (CR). Complement receptor type 1 (CR1) is a
monomeric trans membrane protein able to bind to complement-
opsonized particle C3b and C4b but not C3bi. Complement receptors
type 3 and 4 (CR3, CR4) are heterodimeric proteins from the integrin
family [83,84]. They contain identical β subunits and distinct α
subunits and they bind to C3bi. CR3 also contains a glucan binding site
that has high specificity for polysaccharides. CR3 is a principal
phagocytic receptor expressed on neutrophils, natural killer cells,
monocytes and macrophages and, because it is part of the class of
integrin adhesion receptors, interacts with the actin cytoskeleton and
intracellular signalling pathways [85,86]. CR1, CR3 and CR4 are
involved in phagocytosis and are very important to promote and
enhance mycobacteria ingestion by the host cells. Among the
complement receptors, CR3 is the major one involved in mediating
mycobacteria ingestion: it mediates about 80% of complement-
opsonized M. tuberculosis phagocytosis. In some works, it has been
studied its lack or block and the result is a reduced or inhibited
phagocytosis of the pathogens [57,85]. Like in other bacteria, in M.
tuberculosis, an alternative pathway of complement activation can be
activated, leading to the opsonisation with C3b and C3bi. Bacteria that
are coated with these molecules can bind to CR1, CR3 and CR4 and be
phagocytized in phagosomes [56,57,86]. Pathogenic mycobacteria have
also developed one more mechanism to acquire opsonic C3 peptides:
they can obtain the complement fragment C2a to form a C3 convertase
on their surface generating opsonically active C3b and, thereby
circuiting the complement cascade [87]. M. tuberculosis binds to the
CR3 lectin site probably through the envelope polysaccharides,
including D-glucan. This binding with CR3 mediated by
polysaccharides provides a mechanism for complement-independent
binding and a mode of binding that promoted CR3-directed
phagocytosis.
Mannose receptor and lipoarabinomannans
The macrophage mannose receptor (MR), also called CD207, is
another receptor belonging to the pattern recognition receptors (PRRs)
family and it is a monomeric trans membrane glycoprotein, consist of a
large extracellular domain with eight carbohydrate-recognition
domains dependent and a little cytoplasmic domain containing a
tyrosine-based motif involved in phagocytosis, endocytosis and
endosomal sorting [88]. MRs are expressed only on the adult
macrophages but not on fresh monocytes and they interact with
mannose residues of glycoconiugates, expressed on the surface of
virulent strains of mycobacteria, as lipoarabinomannan (LAM) and
mannose-capped lipoarabinomannan (ManLAM), even if LAM can
bind also to the complement receptor type 3. The binding between
these molecules and mannose receptor is the first interaction occurring
during bacteria phagocytosis by macrophages; however, this
association can depend on the amount of bacterial surface ManLAM.
After the initial step of phagocytosis and macrophages activation by
mycobacterial antigens, the MR expression is strongly down regulated
and the binding of M. tuberculosis is reduced; hence, the role of MR
after the early stages of infection is likely to be minor. LAM is an
amphipathic lipoglycan consisting of a glycerolphosphatidyl anchor, a
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D-mannan core, a D-arabinan domain and various carbohydrate
capping motifs. Lipoarabinomannan is synthesized through addition
of mannose residues to phosphoinositol by a series of
mannosyltransferases to produce phosphatidylmyo-inositol
mannosides (PIMs) and lipomannan (LM). PIM and LM are then
glycosylated with arabinan to form LAM. LAM, besides to be an
important cell wall component, is one of the most important virulence
factors of mycobacteria because is involved in the bacterium uptake by
macrophages and in the modulation of macrophage response
activating anti-inflammatory effects. These mechanisms include the
inhibition of the activity of macrophage PKC and MAPK leading to the
arrest of INF-γ transcription and the block of respiratory burst leading
to neutralization of cytotoxic oxygen free radicals produced by
macrophages [43,89]. One type of LAM is mannose-capped
lipoarabinomannan (ManLAM): they are characterized by the
presence of mannosyl caps on the terminal D-arabinan. This
modification is present only in some species of mycobacteria like
Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium
leprae and Mycobacterium avium: the other species can carry some
variations of it or no ManLAM. ManLAM has been shown to have
immunosuppressive effects by stimulating IL-10 production: it inhibits
the production of IL-12 interfering with TLRs, and TNF production. It
also modulates M. tuberculosis-induced macrophage apoptosis
through the binding with host mannose receptors; this is particularly
important in deactivating host macrophages to allow the bacteria to
survive and multiply within them.
Dendritic cell-specific intercellular adhesion molecule-3-
grabbing non integrin
Dendritic cell-specific intercellular adhesion molecule-3-grabbing
non-integrin (DC-SIGN) is a C-type lectin receptors expressed mainly
on the surface of dendritic cells but also on the macrophages [90]. It is
a carbohydrates recognition receptor that can bind to the bacterial
surface mannose type carbohydrates such as Man-LAM and
lipoarabinomannans: through this binding, it can induce bacteria
phagocytosis and IL-10 production to promote an anti-inflammatory
response, as already mentioned [63,75].
Collectin family
Collectins (collagen-containing C-type lectins) belong to the innate
immune system and they are pattern recognition receptors (PRRs)
forming a family of collagenous Ca2+-dependent defense lectins [64].
Their function is to bind to lipids or oligosaccharide structures located
on the surface of microorganisms. Binding of collectins to
microorganisms enhances their elimination through mechanisms
as complement activation, opsonisation and phagocytosis. Surfactant
protein A (SP-A) and surfactant protein D (SP-D) are proteins
belonging to the collectin family and they are produced by the
respiratory epithelium. As surfactant proteins, they are very important
to maintain lung physiology and integrity because they are also pattern
recognition receptors (PRRs) involved in the innate immunity system
[91,92]. Their calcium-dependent binding to the surface
glycoconjugates of the pathogens enhances the uptake of the pathogen
into the macrophages [93,94]. SP-A and SP-D are important to
modulate the early stages of interaction between the host and
mycobacteria upon the lung [95-99]. Both of them can bind to
mycobacterial lipoarabinomannans but only SP-A can interact
additionally with exposed glycoproteins in the cell wall of the
pathogens [100-102]. It also can stimulate the expression of the other
receptors involved in immunity response like complement receptor 3
and scavenger receptor [103,104]. Moreover, they can modulate the
inflammatory response by regulating the cytokine production, the
oxygen and nitrogen reactive species formation and functioning as
chemo attractants for alveolar neutrophils and monocytes [105].
Scavenger receptors
Scavenger receptors belong to a wide family of cell surface trans
membrane glycoproteins and they recognize macromolecules having a
negative charge including lipopolysaccharides (LPS) of Gram-negative
bacteria and lipoteichoic acid of Gram-positive bacteria [106]. It is not
yet known if scavenger receptors can activate the cytoskeleton to
internalize bacteria but we know they play an important role in innate
immunity and macrophage regulation. CD163 (cluster of
differentiation 163) is a cell-surface glycoprotein receptor cysteine-rich
belonging to superfamily class B; it is a receptor for haemoglobin-
haptoglobin complex but it is also located on monocytes and
macrophages to recognize bacteria. It can bind to both Gram-positive
and Gram-negative bacteria and act as innate immune sensor. Its
interaction with pathogens promotes the pro-inflammatory cytokines
and other inflammatory mediators’ production as TNF-α, IL-1β, IL-6
and IL-10, proving the CD163 role in immune response [107-112].
CD14
CD14 is a cell surface receptor without a cytoplasmatic and trans
membrane domain, anchored to the cell through a lipid structure and
modified by a glycan motif. It especially binds to Gram-negative
bacteria LPS but it can also bind to Gram-positive lipoteichoic acids
and peptidoglycan. CD14 can also interact with mycobacterial LAM
and, thereby, stimulates the secretion of IL-8 by macrophages
[113,114]. It has been found that CD14 is not so important in
mediating phagocytosis but, after mycobacterial infection, its
expression on the surface is up regulate, demonstrating that this
pathogen can modulate the host immune response [115,116].
Cytokines and chemokine production driven by
Mycobacterium tuberculosis
Pro-inflammatory cytokines: The recognition and the phagocytosis
of mycobacteria lead the macrophages and dendritic cells to produce
pro-inflammatory cytokines and chemokines that have an important
role in inflammatory response and in the outcome of the infection.
TNF-α: This cytokine has a key role in regulating the pathology of
tuberculosis and the immune response. It can act through the binding
with its receptor, TNF-αR, and induce further macrophages activation,
apoptosis of infected macrophages and production of reactive nitrogen
intermediates and the formation of granuloma.
Mycobacteria can hinder the action of TNF-α and increase the
probability of survival. The importance of this strategy has been
demonstrated [12,117]: mice treated with antibodies against TNF-α or
its receptor had increased susceptibility to the infection and showed
malformed granulomas.
IL-6: this cytokine is produced early at the site of infection and it
seems to have both pro- and anti-inflammatory features but its
functions are not fully understood yet. In some experiments [118,119]
it has been demonstrated IL-6 anti-inflammatory role. Indeed, it
inhibited the production of TNF-α and other pro-inflammatory
cytokines and, in vitro, it enhanced mycobacteria growth. Another
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work [120] supports its pro-inflammatory function since the lack of
IL-6 increased the susceptibility to the disease.
IL-12: it is produced mainly by phagocytic cells after the
phagocytosis of the pathogens. IL-12 has an important role in inducing
INF-γ production. IL-12 knockout mice and patients with genetic
mutation in the genes encoding IL-12 have a reduced capability to
produce INF-γ and an enhanced susceptibility to be infected
[121-124].
INF-γ: this cytokine is particularly important in response to
tuberculosis and is synthetized by CD4 and CD8 T cells and natural
killer cells after the infection in response to mycobacterial infection.
INF-γ has an essential role in activating macrophages and stimulating
the antigen processing and presentation. Its lack can be harmful: it
enhances extremely the susceptibility to tuberculosis because it wreaks
defective macrophage activation and a decreased production of NOS2
and thereby of reactive nitrogen intermediates.
IL-18/IL-15: these molecules are involved in induction of INF-γ
production as IL-12. They also have a role in stimulating the
production of other cytokines, chemokines and transcription factors
essential for immune response. Moreover, IL-15 is important in
stimulating T cells and natural killer cells proliferation and activation
[125].
Chemokines
Chemokines are chemotactic cytokines responsible for recruitment
of immune system cells to the site of the infection. A wide number of
chemokines has been found but some of them have a major
importance such as IL-8 and MCP-1. IL-8 is synthetized by
macrophages and by pulmonary epithelial cells after pathogens
phagocytosis or stimulation with mycobacterial antigens and it attracts
immune cells like T lymphocytes, neutrophils and monocytes. Like for
the other chemokines, IL-8 production depends on the presence of
TNF-α and its pathway because, if this cytokine is missing, IL-8
production is blocked [126]. Another important chemokine is
monocyte chemo attractant protein 1 (MCP-1) that is produced by
monocytes and macrophages to let it act on themselves. A lack or
deficiency of this protein or its receptor leads to have problems in the
granuloma formation and a low and not effective immune response
[127,128].
Anti-Iflammatory cytokines
After mycobacteria infection, the host starts producing also anti-
inflammatory cytokines to hinder the pro-inflammatory cytokines
effects due to the pathogens.
IL-10: this cytokine is formed by infected macrophages after
bacteria phagocytosis or after stimulation with LAM. Its effect is down
regulation of production of INF-γ, TNF-α and IL-12 [129].
TGF-β: it is produced by dendritic cells and monocytes to inhibit
cell-mediated immunity. In macrophages, it hinders the antigen
processing and presentation, the pro-inflammatory cytokines
production and the cell activation. In T cells, it opposes to cells
proliferation and INF-γ production [130].
IL-4: like TGF-β, it can suppress INF-γ production and
macrophages activation.
High levels of IL-4 lead to a further progression of the infection and
with a reactivation of a latent disease [131,132].
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